Literature DB >> 12435756

Can tuberculosis be controlled?

Thomas R Frieden1.   

Abstract

BACKGROUND: Tuberculosis (TB) is nearly 100% curable. However, the ability of medical and public health interventions to control TB, particularly in developing countries, is often doubted.
METHODS: We reviewed data for the amenability of TB to control. We considered separately control of deaths, prevalence, rate of infection and incidence.
RESULTS: Tuberculosis mortality can be reduced by more than 80% in less than 5 years. The prevalence of TB can be reduced by 30% or more annually; sustained annual decreases of 17% have been documented in a developing country. The TB infection rate can be reduced by 15% annually. In the absence of human immunodeficiency virus (HIV), TB incidence can be decreased by as much as 25% per year and up to 10% annually in developing countries. A high prevalence of untreated HIV infection in the adult population of a developing country will inevitably result in a significant increase in TB incidence despite optimal use of currently available technologies.
CONCLUSIONS: Tuberculosis can be controlled if appropriate policies are followed, effective clinical and public health management is ensured, and there are committed and co-ordinated efforts from within and outside the health sector. However, in the context of a large epidemic of AIDS, TB incidence will inevitably increase. By 2001, less than 30% of global TB cases were reported to have received effective diagnosis, treatment and monitoring. Rapid expansion of effective TB control services is urgently required, both to avert the continued high burden of morbidity and mortality from TB and because of the HIV pandemic.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435756     DOI: 10.1093/ije/31.5.894

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  6 in total

1.  Antituberculosis IgG antibodies as a marker of active Mycobacterium tuberculosis disease.

Authors:  Ryan J Welch; Kathleen M Lawless; Christine M Litwin
Journal:  Clin Vaccine Immunol       Date:  2012-02-01

2.  Evaluation of five antibody detection tests for diagnosis of bovine paratuberculosis.

Authors:  Michael T Collins; Scott J Wells; Kristine R Petrini; James E Collins; Ronald D Schultz; Robert H Whitlock
Journal:  Clin Diagn Lab Immunol       Date:  2005-06

Review 3.  Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review.

Authors:  Edine W Tiemersma; Marieke J van der Werf; Martien W Borgdorff; Brian G Williams; Nico J D Nagelkerke
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

4.  Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis.

Authors:  Ferdinand M Mugusi; Saurabh Mehta; Eduardo Villamor; Willy Urassa; Elmar Saathoff; Ronald J Bosch; Wafaie W Fawzi
Journal:  BMC Public Health       Date:  2009-11-12       Impact factor: 3.295

5.  Tuberculosis incidence in Portugal: spatiotemporal clustering.

Authors:  Carla Nunes
Journal:  Int J Health Geogr       Date:  2007-07-11       Impact factor: 3.918

6.  Tuberculosis management practices by private practitioners in Andhra Pradesh, India.

Authors:  Shanta Achanta; Jyoti Jaju; Ajay M V Kumar; Sharath Burugina Nagaraja; Srinivas Rao Motta Shamrao; Sasidhar Kumar Bandi; Ashok Kumar; Srinath Satyanarayana; Anthony David Harries; Sreenivas Achutan Nair; Puneet K Dewan
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.